세계의 트랜스펙션 기술 시장, 점유율, 규모, 동향, 산업 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2024-2032년)

The global Transfection Technologies market size is expected to reach USD 2.33 billion by 2032, according to a new study by Polaris Market Research. The report "Transfection Technologies Market Share, Size, Trends, Industry Analysis Report, By Product (Equipment, Kits and Reagents); By Application; By End Use; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The transfection technologies market is witnessing growth driven by increased research in functional genomics. Functional genomics focuses on understanding gene function and interactions within an organism's genome. Transfection technologies facilitate this research by delivering nucleic acids into cells to manipulate gene expression and study biological processes. As researchers explore gene regulation and cellular pathways, the demand for advanced transfection methods rises. Additionally, the emergence of genome editing tools like CRISPR-Cas9 amplifies the need for efficient transfection techniques. With ongoing advancements in functional genomics research and therapeutic development, the transfection technologies market is expanding to meet the evolving demands of the biotechnology and pharmaceutical sectors.

Regenerative medicine aims to restore tissue and organ function, offering promising treatments for chronic diseases and injuries. Transfection technologies are crucial in this field, delivering therapeutic nucleic acids like DNA and RNA into target cells for tissue regeneration and immune modulation. The increased research and development in regenerative medicine results in greater demand for advanced transfection technologies ensuring precise delivery of therapeutic payloads.

The transfection technologies market is also growing due to the surge in RNA-based therapeutics. These therapies, including mRNA vaccines and RNAi treatments, hold promise for diseases like cancer and genetic disorders. Transfection technologies are pivotal, delivering RNA molecules into cells for expression and therapeutic effects. They ensure precise and efficient delivery, vital for modulating gene expression and stimulating immune responses.

Traditional 2D cell cultures lack the complexity of in vivo environments, limiting drug development and disease modeling. In contrast, 3D models closely replicate physiological conditions, offering more accurate results. Transfection technologies play a crucial role by delivering nucleic acids into 3D cultures, enabling gene expression studies and signaling pathway analysis. These models are increasingly used in drug screening and personalized medicine, boosting demand for efficient transfection methods. As biomedical researchers and pharmaceutical companies embrace 3D cell culture models, the transfection technologies market sees substantial growth to support innovative research and development efforts.

Transfection Technologies Market Report Highlights

In 2023, the kits and reagents segment held significant revenue share owing to wide range of applications, convenience & ease of use, and consistency & reproducibility.

In 2023, the therapeutic delivery segment held significant revenue share owing to rising demand for gene therapy, advancements in drug delivery, and emergence of RNA therapeutics.

In 2023, the pharmaceutical and biotech companies segment held significant revenue share owing to greater demand from drug discovery and development, biologics production, and regulatory compliance and quality standards.

In 2023, North America region accounted for a significant market share due to strong biotechnology and pharmaceutical industry, advanced healthcare infrastructure, and high research and development spending.

The market is highly competitive owing to the existence of market players with a global presence, including Bio-Rad Laboratories, Inc., GenScript Biotech Corporation, Lonza Group Ltd., Merck KGaA, Mirus Bio LLC, Promega Corporation, QIAGEN N.V., and Thermo Fisher Scientific Inc. among others.

Polaris Market Research has segmented the Transfection Technologies market report based on product, application, end use, and region:

Transfection Technologies, Product Outlook (Revenue - USD Billion, 2019 - 2032)

• Equipment
• Kits and Reagents

Transfection Technologies, Application Outlook (Revenue - USD Billion, 2019 - 2032)

• Protein Production
• Biomedical Research
• Therapeutic Delivery
• Others

Transfection Technologies, End Use Outlook (Revenue - USD Billion, 2019 - 2032)

• CROs and CDMOs
• Pharmaceutical and Biotech Companies
• Research Institutes
• Others

Transfection Technologies, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

• North America
• U.S.
• Canada
• Europe
• France
• Germany
• UK
• Italy
• Netherlands
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• Japan
• China
• India
• Malaysia
• Indonesia
• South Korea
• Australia
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East & Africa
• Saudi Arabia
• UAE
• Israel
• South Africa
• Rest of Middle East & Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Transfection Technologies Market Insights

• 4.1. Transfection Technologies Market - End Use Snapshot
• 4.2. Transfection Technologies Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Rise in gene therapy and cell-based therapies is projected to spur the product demand
    • 4.2.1.2. Expansion of biopharmaceutical research is expected to drive transfection technologies market growth
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Transfection efficiency and variability
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Transfection Technologies Market End Use Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Transfection Technologies Market, by Application

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
• 5.3. Protein Production
  • 5.3.1. Global Transfection Technologies Market, by Protein Production, by Region, 2019-2032 (USD Billion)
• 5.4. Biomedical Research
  • 5.4.1. Global Transfection Technologies Market, by Biomedical Research, by Region, 2019-2032 (USD Billion)
• 5.5. Therapeutic Delivery
  • 5.5.1. Global Transfection Technologies Market, by Therapeutic Delivery, by Region, 2019-2032 (USD Billion)
• 5.6. Others
  • 5.6.1. Global Transfection Technologies Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Transfection Technologies Market, by Product

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
• 6.3. Equipment
  • 6.3.1. Global Transfection Technologies Market, by Equipment, by Region, 2019-2032 (USD Billion)
• 6.4. Kits and Reagents
  • 6.4.1. Global Transfection Technologies Market, by Kits and Reagents, by Region, 2019-2032 (USD Billion)

7. Global Transfection Technologies Market, by End Use

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
• 7.3. CROs and CDMOs
  • 7.3.1. Global Transfection Technologies Market, by CROs and CDMOs, By Region, 2019-2032 (USD Billion)
• 7.4. Pharmaceutical and Biotech Companies
  • 7.4.1. Global Transfection Technologies Market, by Pharmaceutical and Biotech Companies, By Region, 2019-2032 (USD Billion)
• 7.5. Research Institutes
  • 7.5.1. Global Transfection Technologies Market, by Research Institutes, By Region, 2019-2032 (USD Billion)
• 7.6. Others
  • 7.6.1. Global Transfection Technologies Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Transfection Technologies Market, by Geography

• 8.1. Key findings
• 8.2. Introduction
  • 8.2.1. Transfection Technologies Market Assessment, By Geography, 2019-2032 (USD Billion)
• 8.3. Transfection Technologies Market - North America
  • 8.3.1. North America: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • 8.3.2. North America: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
  • 8.3.3. North America: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • 8.3.4. Transfection Technologies Market - U.S.
    • 8.3.4.1. U.S.: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
    • 8.3.4.2. U.S.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
    • 8.3.4.3. U.S.: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • 8.3.5. Transfection Technologies Market - Canada
    • 8.3.5.1. Canada: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
    • 8.3.5.2. Canada.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
    • 8.3.5.3. Canada: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
• 8.4. Transfection Technologies Market - Europe
  • 8.4.1. Europe: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • 8.4.2. Europe.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
  • 8.4.3. Europe: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • 8.4.4. Transfection Technologies Market - UK
    • 8.4.4.1. UK: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
    • 8.4.4.2. UK.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
    • 8.4.4.3. UK: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • 8.4.5. Transfection Technologies Market - France
    • 8.4.5.1. France: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
    • 8.4.5.2. France.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
    • 8.4.5.3. France: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • 8.4.6. Transfection Technologies Market - Germany
    • 8.4.6.1. Germany: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
    • 8.4.6.2. Germany.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
    • 8.4.6.3. Germany: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • 8.4.7. Transfection Technologies Market - Italy
    • 8.4.7.1. Italy: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
    • 8.4.7.2. Italy.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
    • 8.4.7.3. Italy: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • 8.4.8. Transfection Technologies Market - Spain
    • 8.4.8.1. Spain: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
    • 8.4.8.2. Spain.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
    • 8.4.8.3. Spain: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • 8.4.9. Transfection Technologies Market - Netherlands
    • 8.4.9.1. Netherlands: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
    • 8.4.9.2. Netherlands.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
    • 8.4.9.3. Netherlands: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • 8.4.10. Transfection Technologies Market - Russia
    • 8.4.10.1. Russia: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
    • 8.4.10.2. Russia.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
    • 8.4.10.3. Russia: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
• 8.5. Transfection Technologies Market - Asia Pacific
  • 8.5.1. Asia Pacific: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • 8.5.2. Asia Pacific.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
  • 8.5.3. Asia Pacific: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • 8.5.4. Transfection Technologies Market - China
    • 8.5.4.1. China: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
    • 8.5.4.2. China.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
    • 8.5.4.3. China: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • 8.5.5. Transfection Technologies Market - India
    • 8.5.5.1. India: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
    • 8.5.5.2. India.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
    • 8.5.5.3. India: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • 8.5.6. Transfection Technologies Market - Malaysia
    • 8.5.6.1. Malaysia: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
    • 8.5.6.2. Malaysia.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
    • 8.5.6.3. Malaysia: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • 8.5.7. Transfection Technologies Market - Japan
    • 8.5.7.1. Japan: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
    • 8.5.7.2. Japan.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
    • 8.5.7.3. Japan: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • 8.5.8. Transfection Technologies Market - Indonesia
    • 8.5.8.1. Indonesia: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
    • 8.5.8.2. Indonesia.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
    • 8.5.8.3. Indonesia: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • 8.5.9. Transfection Technologies Market - South Korea
    • 8.5.9.1. South Korea: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
    • 8.5.9.2. South Korea.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
    • 8.5.9.3. South Korea: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
• 8.6. Transfection Technologies Market - Middle East & Africa
  • 8.6.1. Middle East & Africa: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • 8.6.2. Middle East & Africa.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
  • 8.6.3. Middle East & Africa: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • 8.6.4. Transfection Technologies Market - Saudi Arabia
    • 8.6.4.1. Saudi Arabia: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
    • 8.6.4.2. Saudi Arabia.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
    • 8.6.4.3. Saudi Arabia: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • 8.6.5. Transfection Technologies Market - UAE
    • 8.6.5.1. UAE: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
    • 8.6.5.2. UAE.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
    • 8.6.5.3. UAE: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • 8.6.6. Transfection Technologies Market - Israel
    • 8.6.6.1. Israel: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
    • 8.6.6.2. Israel.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
    • 8.6.6.3. Israel: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • 8.6.7. Transfection Technologies Market - South Africa
    • 8.6.7.1. South Africa: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
    • 8.6.7.2. South Africa.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
    • 8.6.7.3. South Africa: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
• 8.7. Transfection Technologies Market - Latin America
  • 8.7.1. Latin America: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
  • 8.7.2. Latin America.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
  • 8.7.3. Latin America: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • 8.7.4. Transfection Technologies Market - Mexico
    • 8.7.4.1. Mexico: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
    • 8.7.4.2. Mexico.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
    • 8.7.4.3. Mexico: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • 8.7.5. Transfection Technologies Market - Brazil
    • 8.7.5.1. Brazil: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
    • 8.7.5.2. Brazil.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
    • 8.7.5.3. Brazil: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)
  • 8.7.6. Transfection Technologies Market - Argentina
    • 8.7.6.1. Argentina: Transfection Technologies Market, by Application, 2019-2032 (USD Billion)
    • 8.7.6.2. Argentina.: Transfection Technologies Market, by End Use, 2019-2032 (USD Billion)
    • 8.7.6.3. Argentina: Transfection Technologies Market, by Product, 2019-2032 (USD Billion)

9. Competitive Landscape

• 9.1. Expansion and Acquisition Analysis
  • 9.1.1. Expansion
  • 9.1.2. Acquisitions
• 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

• 10.1. Altogen Biosystems
  • 10.1.1. Company Overview
  • 10.1.2. Financial Performance
  • 10.1.3. Product Benchmarking
  • 10.1.4. Recent Development
• 10.2. Bio-Rad Laboratories, Inc.
  • 10.2.1. Company Overview
  • 10.2.2. Financial Performance
  • 10.2.3. Product Benchmarking
  • 10.2.4. Recent Development
• 10.3. GenScript Biotech Corporation
  • 10.3.1. Company Overview
  • 10.3.2. Financial Performance
  • 10.3.3. Product Benchmarking
  • 10.3.4. Recent Development
• 10.4. Lonza Group Ltd
  • 10.4.1. Company Overview
  • 10.4.2. Financial Performance
  • 10.4.3. Product Benchmarking
  • 10.4.4. Recent Development
• 10.5. MaxCyte, Inc.
  • 10.5.1. Company Overview
  • 10.5.2. Financial Performance
  • 10.5.3. Product Benchmarking
  • 10.5.4. Recent Development
• 10.6. Merck KGaA
  • 10.6.1. Company Overview
  • 10.6.2. Financial Performance
  • 10.6.3. Product Benchmarking
  • 10.6.4. Recent Development
• 10.7. Mirus Bio LLC
  • 10.7.1. Company Overview
  • 10.7.2. Financial Performance
  • 10.7.3. Product Benchmarking
  • 10.7.4. Recent Development
• 10.8. OriGene Technologies, Inc.
  • 10.8.1. Company Overview
  • 10.8.2. Financial Performance
  • 10.8.3. Product Benchmarking
  • 10.8.4. Recent Development
• 10.9. Polyplus-transfection SA
  • 10.9.1. Company Overview
  • 10.9.2. Financial Performance
  • 10.9.3. Product Benchmarking
  • 10.9.4. Recent Development
• 10.10. Promega Corporation
  • 10.10.1. Company Overview
  • 10.10.2. Financial Performance
  • 10.10.3. Product Benchmarking
  • 10.10.4. Recent Development
• 10.11. QIAGEN N.V.
  • 10.11.1. Company Overview
  • 10.11.2. Financial Performance
  • 10.11.3. Product Benchmarking
  • 10.11.4. Recent Development
• 10.12. SignaGen Laboratories
  • 10.12.1. Company Overview
  • 10.12.2. Financial Performance
  • 10.12.3. Product Benchmarking
  • 10.12.4. Recent Development
• 10.13. Takara Bio Inc
  • 10.13.1. Company Overview
  • 10.13.2. Financial Performance
  • 10.13.3. Product Benchmarking
  • 10.13.4. Recent Development
• 10.14. Thermo Fisher Scientific Inc.
  • 10.14.1. Company Overview
  • 10.14.2. Financial Performance
  • 10.14.3. Product Benchmarking
  • 10.14.4. Recent Development
• 10.15. Viromer
  • 10.15.1. Company Overview
  • 10.15.2. Financial Performance
  • 10.15.3. Product Benchmarking
  • 10.15.4. Recent Development